Reach Us +441414719275
Real Life HAART Efficacy in Chronically HIV-1 Infected Children 15-Year Follow-Up | OMICS International | Abstract
ISSN 2155-6113

Journal of AIDS & Clinical Research
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Real Life HAART Efficacy in Chronically HIV-1 Infected Children 15-Year Follow-Up

Fabrice Monpoux1*, Amandine Rubio2, Charlotte Sakarovitch3, Eric Fontas3, Jacqueline Cottalorda-Dufayard4 and Christian Pradier5

1Unité d’Hémato-Immuno-Cancerologie Infantile-GCS de Pédiatrie, Université de Nice Sophia-Antipolis–NICE cedex 3, France

2Clinique de Pédiatrie. Hôpital Couple Enfant, Université Joseph Fourier–GRENOBLE cedex 09, France

3Département de la Recherche Clinique et de l’Innovation, Université de Nice Sophia-Antipolis–NICE cedex 3, France

4Laboratoire de Virologie, Université de Nice Sophia-Antipolis–NICE cedex 3, France

5Département de santé publique, Université de Nice Sophia-Antipolis–NICE cedex 3, France

*Corresponding Author:
Fabrice Monpoux
Unité d’Hémato-Immuno-Cancerologie Infantile
GCS de Pediatrie, Hôpital de l’Archet 2
151, route de Saint Antoine
de Ginestière 06202 Nice
Cedex 3, France
Tel: 33-0492036064
Fax: 33-0492036578
E-mail: [email protected]

Received Date: April 23, 2012; Accepted Date: October 26, 2012; Published Date: October 28, 2012

Citation: Monpoux F, Rubio A, Sakarovitch C, Fontas E, Cottalorda-Dufayard J, et al. (2012) Real Life HAART Efficacy in Chronically HIV-1 Infected Children 15-Year Follow-Up. J AIDS Clinic Res 3:178. doi:10.4172/2155-6113.1000178

Copyright: © 2012 Monpoux F, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Background: It is now widely accepted that the antiretroviral first line-treatment basis in HIV-1 infected children is a combination of 2 nucleoside reverse transcriptase inhibitors and 1 protease inhibitor or 1 non NRTI. However, after few months or years, some patients presented with virological failure. Objective: Using a “real life conditions” cohort, we aimed to study the median duration of Viral Controlled Replication (VCR) and the factors associated with failure in infected children. Methods: Thirty six HIV-1 infected patients were followed between September 1996 and September 2010. Children were included starting from the date of initiation of their first successful HAART. Duration of effective VCR was defined as a length, in months, from inclusion to virological failure defined as a HIV-1 PCR-RNA higher than 400 c/ml. Results: The overall median VCR duration was 46.2 months. Duration was significantly shorter in patients: previously exposed to mono therapies, with CD4 count lower than 350 and with PI-based HAART. After adjustment, the negative effect of PI-based HAART regimen compared to nNRTI-based HAART remained significant (HR=5.7 [95%CI=1.43-22.7]). Conclusion: Therefore, retrospective analysis of “real life” condition data in observational cohort may contribute to a better understanding of non optimal virological care.


Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri and Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version